Another important role of CXCR3 ligands in anti-tumor immunity relies on the effectiveness of CXCL4 and CXCL4L1 (factors produced by platelets) at inhibiting lymphangiogenesis and preventing metastatic escape of tumor cells via the lymphatic vasculature (17). This evidence concerns the gene PF4V1 and neoplasm.